...
首页> 外文期刊>Neurourology and urodynamics. >Systematic review of surgical treatment of post radical prostatectomy stress urinary incontinence
【24h】

Systematic review of surgical treatment of post radical prostatectomy stress urinary incontinence

机译:前列腺癌根治术后应激性尿失禁手术治疗的系统评价

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Context Stress urinary incontinence (SUI) after radical prostatectomy (RP) continues to be a significant problem with several implications including patient quality of life and other critical postoperative outcomes. Objectives To report the results in terms of efficacy (pad count, 24hr pad test, QOL questionnaires) and safety (complication rate and type of complications) of all surgical devices approved for the treatment of SUI after RP. Evidence Acquisition A systematic review was conducted in accordance with the PRISMA Statement. A literature search was carried out through the PubMed/Medline, SCOPUS, and Web of Science databases using the keywords incontinence, radical prostatectomy, and treatment. Inclusion criteria were: number of patients higher than 30, mean follow up longer than 12 months and definition of a successful outcome as the use of 0 to 1 safety pads a day. Evidence Synthesis 113 papers underwent primary review. 51 papers met the inclusion criteria with a total sample size of 4022 patients. Efficacy (0-1 safety pads) was on average 65.7% for AUS, 48.2% for Invance Sling, 48.8% for Advance Sling, 64.2% for ProACT. Twenty four hour pad test and QOL questionnaires were respectively available only in 4 and 18 studies. The overall complication rate was 19.43% for AUS, 7.4% for Invance Sling, 12.3% for Advance Sling, 12.3% for ProACT. Authors' Conclusions Due to the poor overall quality of available studies, it was impossible to identify or refute clinically important differences between the alternative surgical procedures. Although our data seems to suggest that AUS has the highest efficacy in the treatment of SUI following RP it is also associated with the highest complication rate, but this may be due to the longest follow up. Larger rigorous trials are needed in order to support this evidence. Neurourol. Urodynam. 35:875-881, 2016. (c) 2015 Wiley Periodicals, Inc.
机译:背景根治性前列腺切除术(RP)后的压力性尿失禁(SUI)仍然是一个重大问题,其影响包括患者的生活质量和其他重要的术后结局。目的报告所有批准用于RP后SUI的手术器械的功效(衬垫计数,24小时衬垫试验,QOL问卷)和安全性(并发症发生率和并发症类型)的结果。证据获取根据PRISMA声明进行了系统的审查。通过PubMed / Medline,SCOPUS和Web of Science数据库使用关键词失禁,根治性前列腺切除术和治疗进行了文献检索。入选标准为:患者数量大于30,平均随访时间超过12个月,并且定义成功的结果为每天使用0到1个安全垫。证据综合113篇论文进行了初审。符合纳入标准的论文51篇,样本总数4022名。 AUS的功效(0-1个安全护垫)平均为65.7%,Invance Sling为48.2%,Advance Sling为48.8%,ProACT为64.2%。仅在4和18个研究中分别提供了24小时的便笺本测试和QOL问卷。 AUS的总并发症发生率为19.43%,Invance Sling为7.4%,Advance Sling为12.3%,ProACT为12.3%。作者的结论由于现有研究的总体质量较差,因此无法确定或驳斥替代性手术程序之间临床上重要的差异。尽管我们的数据似乎表明AUS在RP后SUI的治疗中具有最高疗效,但它也与最高并发症发生率相关,但这可能是由于随访时间最长。为了支持这一证据,需要进行更严格的试验。神经尿素。 Urodynam。 35:875-881,2016.(c)2015威利期刊公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号